Patent · US Active

Compounds which modulate the CB2 receptor

US7935715B2 · kind B2 · utility

25Cited by

31References

3Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Angela Berry · Gaylordsville, US
Pier Francesco Cirillo · Woodbury, US
Eugene Richard Hickey · Danbury, US
Doris Riether · Biberach an der Riß, DE
David Thomson · Ridgefield, US
Monika Ermann · Wantage, GB
James Edward Jenkins · Hungerford, GB
Innocent Mushi · Felton, GB
Malcolm Taylor · Biggenden, AU
Christopher Francis Palmer · Abingdon, GB
Nigel James Blumire · Biggenden, AU

Key dates

Filing date	Jul 23, 2007
Grant date	May 3, 2011
Priority date	—
Expiry date	Sep 10, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compound of formula (I)are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.